Literature DB >> 19776284

CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Erin G Reed-Geaghan1, Julie C Savage, Amy G Hise, Gary E Landreth.   

Abstract

Microglia are the brain's tissue macrophages and are found in an activated state surrounding beta-amyloid plaques in the Alzheimer's disease brain. Microglia interact with fibrillar beta-amyloid (fAbeta) through an ensemble of surface receptors composed of the alpha(6)beta(1) integrin, CD36, CD47, and the class A scavenger receptor. These receptors act in concert to initiate intracellular signaling cascades and phenotypic activation of these cells. However, it is unclear how engagement of this receptor complex is linked to the induction of an activated microglial phenotype. We report that the response of microglial cells to fibrillar forms of Abeta requires the participation of Toll-like receptors (TLRs) and the coreceptor CD14. The response of microglia to fAbeta is reliant upon CD14, which act together with TLR4 and TLR2 to bind fAbeta and to activate intracellular signaling. We find that cells lacking these receptors could not initiate a Src-Vav-Rac signaling cascade leading to reactive oxygen species production and phagocytosis. The fAbeta-mediated activation of p38 MAPK also required CD14, TLR4, and TLR2. Inhibition of p38 abrogated fAbeta-induced reactive oxygen species production and attenuated the induction of phagocytosis. Microglia lacking CD14, TLR4, and TLR2 showed no induction of phosphorylated IkappaBalpha following fAbeta. These data indicate these innate immune receptors function as members of the microglial fAbeta receptor complex and identify the signaling mechanisms whereby they contribute to microglial activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776284      PMCID: PMC2778845          DOI: 10.1523/JNEUROSCI.3158-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  106 in total

1.  MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis.

Authors:  Ling Kong; Bao-Xue Ge
Journal:  Cell Res       Date:  2008-07       Impact factor: 25.617

2.  Beta-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner.

Authors:  Angela M Floden; Colin K Combs
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

3.  p38 kinase is activated in the Alzheimer's disease brain.

Authors:  K Hensley; R A Floyd; N Y Zheng; R Nael; K A Robinson; X Nguyen; Q N Pye; C A Stewart; J Geddes; W R Markesbery; E Patel; G V Johnson; G Bing
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

4.  Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation.

Authors:  Liya Qin; Guorong Li; Xun Qian; Yuxin Liu; Xuefei Wu; Bin Liu; Jau-Shyong Hong; Michelle L Block
Journal:  Glia       Date:  2005-10       Impact factor: 7.452

5.  Mechanism for phosphorylation-induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase.

Authors:  T Ago; H Nunoi; T Ito; H Sumimoto
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

6.  Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase.

Authors:  H Sumimoto; K Hata; K Mizuki; T Ito; Y Kage; Y Sakaki; Y Fukumaki; M Nakamura; K Takeshige
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

7.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

8.  Modulation of lipopolysaccharide-induced monocyte activation by heparin-binding protein and fucoidan.

Authors:  M Heinzelmann; H C Polk; F N Miller
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

Authors:  Malabendu Jana; Carlos A Palencia; Kalipada Pahan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A.

Authors:  Woojin Scott Kim; Christine M Ordija; Mason W Freeman
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

View more
  251 in total

1.  Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease.

Authors:  Jean-Philippe Michaud; Karine L Richard; Serge Rivest
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

Authors:  Sungho Lee; Nicholas H Varvel; Megan E Konerth; Guixiang Xu; Astrid E Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

4.  Toll/interleukin-1 receptor domain-containing adapter inducing interferon-β mediates microglial phagocytosis of degenerating axons.

Authors:  Suneil Hosmane; Million Adane Tegenge; Labchan Rajbhandari; Prech Uapinyoying; Nishant Ganesh Kumar; Nitish Thakor; Arun Venkatesan
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 5.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

6.  Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.

Authors:  John K Hermann; Madhumitha Ravikumar; Andrew J Shoffstall; Evon S Ereifej; Kyle M Kovach; Jeremy Chang; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Patrick Smith; Grace Protasiewicz; Jingle Jiang; Stephen M Selkirk; Robert H Miller; Steven Sidik; Nicholas P Ziats; Dawn M Taylor; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2018-04       Impact factor: 5.379

7.  Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.

Authors:  Jean-Philippe Michaud; Maxime Hallé; Antoine Lampron; Peter Thériault; Paul Préfontaine; Mohammed Filali; Pascale Tribout-Jover; Anne-Marie Lanteigne; Rachel Jodoin; Christopher Cluff; Vincent Brichard; Rémi Palmantier; Anthony Pilorget; Daniel Larocque; Serge Rivest
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-15       Impact factor: 11.205

8.  Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Authors:  Douglas G Walker; Tiffany M Tang; Lih-Fen Lue
Journal:  Exp Neurol       Date:  2018-08-01       Impact factor: 5.330

9.  Oligomeric Aβ-induced microglial activation is possibly mediated by NADPH oxidase.

Authors:  Juan Li; Jing Yu Yang; Xue Chun Yao; Xue Xue; Qing Chun Zhang; Xiao Xiao Wang; Ling Ling Ding; Chun Fu Wu
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

Review 10.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.